Patients experience significant burdens (fear, discomfort, disruptions to their lives) with geographic atrophy (GA) treatments that are dosed monthly or every …
PRESS RELEASES
GA and Loss of Central Vision
Geographic atrophy (GA) is sight threatening. It causes loss of central vision, development of scotomas (blind spots), reduced reading speed and night vision …
Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
NEW YORK and LONDON, September 5, 2023(GLOBE NEWSWIRE) – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced …
[Read more...] about Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
